subtle neurochemical and behavioural phenotypes. This paper explores key issues that need to be addressed in future research. There is a need to define the timing and duration of the 'critical window' during which low vitamin D status is associated with differential and adverse brain outcomes. We discuss the role for 'two-hit hypotheses', which propose that adult vitamin D deficiency leaves the brain more vulnerable to secondary adverse exposures, and thus may exacerbate disease progression. Finally, we explore the evidence implicating a role for vitamin D in rapid, non-genomic mechanisms that may involve L-type calcium channels and brain function.
Introduction
Over the last decade there has been a marked increase in research exploring the role of vitamin D in the brain. This research was inspired by the pioneering work of
Stumpf [1] , Wion and Garcion [2, 3] . In a landmark study by Eyles and colleagues, the distribution of the vitamin D receptor (VDR) and the key rate limiting enzyme involved in the production of 1,25 dihydroxyvitamin D (1,25(OH) 2 D), was mapped in the adult brain [4] . Of particular interest, the distribution of VDR in certain brain regions suggested that vitamin D may influence particular neurotransmitters and cortical function. For example, expression of the VDR was identified in the hippocampus and prefrontal cortex -brain regions required for learning and memory, and executive control, and implicated in a range of neuropsychiatric disorders. VDR expression appeared most prominent in the substantia nigra, a region rich in dopaminergic neurons. Subsequent research has provided robust evidence linking vitamin D related mechanisms and dopaminergic neurotransmission [5] [6] [7] [8] .
A growing body of epidemiological research has also linked vitamin D status and risk of brain disorders. The field has moved on from the early ecological studies (e.g those based on latitude gradients and seasonal variations), to stronger analytic methods that have directly measured vitamin D status. These studies have included (a) cross-sectional studies based on case-control samples, or (b) longitudinal cohort studies linking baseline vitamin D status and later incidence brain disorders. With respect to brain disorders, multiple sclerosis has long been linked to vitamin D [9] [10] [11] .
Other brain disorders of interest to vitamin D related epidemiology research include (a) dementia and cognitive function [12] [13] [14] , (b) Parkinson's disease [15] , (c) 4 depression [16] , (d) schizophrenia or psychosis [17] [18] [19] [20] and (e) autism [21, 22] . The results of these studies are by no means consistent, but provide sufficient evidence to justify ongoing studies -the evidence of these studies is covered more extensively in reviews by Deluca and colleagues [23] and Groves and colleagues [24] . In the current article, we take a more forward-looking perspective and suggest key areas that are needed to inform future research.
Are there 'critical windows' when low vitamin D differentially impacts on brain function?
In keeping with the well known pro-differentiating and anti-proliferating properties of beyond gestation and weaning induce rickets, which confounds the interpretation of many behavioural phenotypes [33] .
In humans, it is also clear that a great deal of brain development happens in the first few years of life. Epidemiological and imaging studies indicate that peri-pubertal and adolescence stages are also implicated in disorders such as schizophrenia [34, 35] .
It is feasible that different brain disorders are associated with different critical windows. Neonatal vitamin D status is linked to the risk of schizophrenia [36] but not multiple sclerosis [37] . Longitudinal birth cohort studies, with repeated measures of vitamin D status at multiple time points, may help define the timing and duration of the critical window [38, 39] .
Adult vitamin D deficiency and brain function -does vitamin D deficiency leave the brain vulnerable to future insults?
As mentioned above, the impact of low vitamin D intake on adult brain function is very different to that in developmental models. The findings based on AVD rat and mouse models tend to be relatively subtle, and vary according to species and strain In summary, there is now strong evidence indicating that 1,25(OH) 2 D impacts on LTCC function, and that these processes are highly relevant to neuronal function.
Indeed, the modulation of calcium entry into neural cells by the 1,25(OH) 2 D could influence a wide range of neuronal functions, such as maturation of the nervous system during development, and/or neuroprotection during adulthood [67, 68] .
In 2013 a major collaborative study from the Psychiatric Genomics Consortium was published in the Lancet [69] . The study combined approximately 30,000 cases of autism, attention deficit disorder, bipolar disorder, major depressive disorder and schizophrenia and 28,000 controls. Across all disorders, SNPs in two LTCC genes were identified that met genome-wide significance (in CACNA1C and CACNB2).
Pathway analysis supported a role for genes involved in calcium channel signalling genes for all five disorders. These findings provide further evidence of the importance of these pathways in neuropsychiatric disorders [70, 71] and possibly in Alzheimer's disease [72] .
Future directions
We Curiously, estrogen directly potentiates LTCC via non-genomic (and estrogen receptor independent) mechanisms [73] . This raises the potential that a wider class of steroid and seco-steroids may also operate via these mechanisms. These are tractable research questions as modern electrophysiology and calcium imaging techniques will be able to further explore and dissect these research questions. Of course, clues from basic neuroscience need to cross-talk with epidemiology (i.e. translational epidemiology) [74] . 
